Australia Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
Australia cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The Australia cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 150.6 million in 2024 and is expected to reach USD 309.5 million by 2035.
- The Australia market is expected to grow at a CAGR of 6.9% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
Cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market data book summary
| Market revenue in 2024 | USD 150.6 million |
| Market revenue in 2035 | USD 309.5 million |
| Growth rate | 6.9% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2035.
- In Asia Pacific, China cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is projected to lead the regional market in terms of revenue in 2035.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 102.3 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 51.73% in 2024. Horizon Databook has segmented the Australia cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
The Australia cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is experiencing robust growth fueled by significant investments.
In November 2023, the Albanese Labor Government announced a USD 48.2 million investment over four years to implement the National Strategy for the Elimination of Cervical Cancer by 2035, along with an additional USD 12.5 million dedicated to supporting cervical cancer elimination efforts in the Indo-Pacific region.
Continuing its proactive approach, in September 2024 the government launched the "Own It" campaign, a USD 10 million initiative designed to promote cervical cancer screening among women aged 25-74. This campaign emphasizes self-collection testing and specifically targets priority groups, including Aboriginal and Torres Strait Islander women.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Australia Type - Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market size, 2024 - 2035 (US$M)
Australia Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
